Market's red hot sector this season, and other top stories of the day

To keep you updated, we send ET Markets Newsletter to your mailbox. In case, you wish to Unsubscribe Click Here

DAILY BRIEF Tue, Aug 14, 2018 #ValueInvestor#IPOs#Q1Results#CrudeOil#ExpertViews SENSEX 37852.00 207.10 NIFTY 50 11435.10 79.35 Gold 29788.00 63.00 USD/INR 69.90 -0.03

TOP OF THE DAY RBI dismisses Kotak Mahindra Bank's plan to dilute promoter stake The private lender had issued preference shares on August 2 to dilute promoter stake. Tech view: Nifty forms bullish candle, but undercurrent is weak After Market: Rupee tumble, most active stocks and Put/Call data F&O: Options show Nifty may hold between 11,350 & 11,500 500% returns in a year! Look which is the red hot sector this season Banks line up sale of KSK, Avantha plants; Adani, Vedanta frontrunners MACD charts show RIL, PNB, IOC among 117 stocks at risk of sharp fall

Top Gainers NSE 4 companies (largecap) appreciated more than 5% Balkrishna Ind. 8.72% Sun Pharma 6.72% More from Gainers Top Losers NSE 2 companies (largecap) price decreased more than -3% Cadila Health -4.05% Abbott India -3.25% More from Losers 52 Week High NSE 31 companies touched new 52-week high today Lincoln Pharma 13.92% Albert David 8.05% More from 52 Week High

AdvertorialFalse income tax refund claims could attract these penalties The income tax department has recently claimed to have busted a racket of fraudulent claim of tax refunds by employees of well known companies. AdvertorialAutomating job skills matching using Artificial Intelligence Finding the right candidates and matching them with the right role is at the core of HR, but it's beyond human capacity to do this without an error, merely on the basis of an individual's resume.

Government looking to divest stake in 6 state-run firms In the Union Budget for financial year 2018-19, the government had set a disinvestment target of Rs 80,000 cro... Sun Pharma beats Street estimates, posts Rs 982 crore profit for Q1 Bitcoin drops below $6,000 as crypto rout worsens Mobius warns of 'real possibility' of capital controls in Turkey

Market moguls Podcast Video Nifty at new highs, but enough good reasons to call it a mirage ETMarkets Evening Podcast: Stocks back in black; should you stay put? RBI rejects Kotak Bk's stake dilution plan

RECOMMENDATIONS State Bank of India Overweight State Bank of India, target Rs 425: Morgan Stanley Overweight NCC Ltd. Buy NCC, target Rs 165: Phillip Capital (India) Buy GAIL (India) Ltd. Buy GAIL (India), target Rs 435: CLSA Buy Dr. Lal Pathlabs Ltd. Buy Dr. Lal Pathlabs, target Rs 1,320: CLSA Buy Pidilite Industries Ltd. Buy Pidilite Industries, target Rs 1166: Kunal Bothra Buy

Rupee crosses 70 in a first; are exporters a sound bet? A weakness in the rupee could support top line of domestic pharma players. A book seeks to crack Warren Buffett code Jet faces tough test, yet to respond to notices from Sebi, bourses India an oasis of comfort among EMs: Citi roadshow

Quick Links Markets Live | Market Stats | IPOs | Technicals | Commodities | Forex

About us|Advertise with us|Feedback|Sitemap|Code of Ethics More Newsletters: Daily Newsletter | Markets Morning | ET Investment Opportunities | Wealth | View all © Times Internet Limited. To ensure delivery directly to your inbox, please add etnotifications@indiatimes.com to your address book today. If you are having trouble viewing this newsletter, please click here, To unsubscribe or edit your subscriptions please click here